Top Story

Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Molecular Imaging
Phase I trial reveals the potential of a new PSMA-PET tracer
The radiotracer detected more lesions in men with metastatic disease than F-18 piflufolastat.
Featured
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Womens Imaging
Radiologists can designate nonmass lesions on breast ultrasound
Coronavirus
MRI
Long COVID's neurological effects persist
Latest News
Obesity Text2
MRI proves effective for tracking results of obesity interventions
December 8, 2025
Phpt
TVR-PET/CT shows promise in primary hyperparathyroidism
December 8, 2025
Acr Logo 2023 400
ACR talks BI-RADS version 2025 with AuntMinnie
December 8, 2025
Screenshot (91)
ACR's Ted Burnes talks advocacy in radiology with AuntMinnie
December 8, 2025
Cases of the Week
Check out our Cases of the Week!
60-year-old woman with right arm weakness
A 60-year-old woman presented to an outside hospital with abdominal pain and fevers found to be secondary to pneumonia.
13-year-old girl with rapid-onset facial swelling
39-year-old man with recurrent cholangitis and abdominal pain
View All Cases
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Molecular Imaging
Phase I trial reveals the potential of a new PSMA-PET tracer
Womens Imaging
Radiologists can designate nonmass lesions on breast ultrasound
MRI
Long COVID's neurological effects persist
MRI
MRI proves effective for tracking results of obesity interventions
Molecular Imaging
TVR-PET/CT shows promise in primary hyperparathyroidism
Nayyar Rishi Thumbnail
AI
Your network doesn't matter anymore
AI
The paradox of AI in lung nodules
Digital X-Ray
AI detects meningiomas on skull x-rays
AI
Collaboration could boost lung cancer screening
AI
Building infrastructure for accessible preventive imaging
Acquisitions
Radiation Oncology/Therapy
Telix and Varian enter research collaboration
MRI
Imaging Biometrics and GE HealthCare expand agreement
AI
Raidium unveils AI-native PACS viewer at RSNA 2025
AI
A2z raises $4.5M in seed round for CT triage system
Digital X-Ray
Virtual Phantoms launches radiation dose estimation software
Podcasts
Latest Episode
Podcast: Sherpa doctor recalls career journey starting at Mt. Everest
More episodes »
Practice Management
Acr Logo 2023 400
ACR talks BI-RADS version 2025 with AuntMinnie
ACR members discussed the need to release the latest version of BI-RADS and what changes breast radiologists can expect.
Virtual Phantoms launches radiation dose estimation software
ACR's Ted Burnes talks advocacy in radiology with AuntMinnie
More Practice Management
More from AuntMinnie
Telix and Varian enter research collaboration
By AuntMinnie.com staff writers
The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.
December 10, 2025
Acquisitions
Imaging Biometrics and GE HealthCare expand agreement
By AuntMinnie.com staff writers
GE HealthCare will now distribute Imaging Biometrics’ Fractional Tumor Burden (FTB) Express and QSMetric software applications.
December 10, 2025
Ai Handshake
Raidium unveils AI-native PACS viewer at RSNA 2025
By AuntMinnie.com staff writers
French precision radiology developer Raidium unveiled its work-in-progress AI-native PACS viewer at RSNA 2025.
December 10, 2025
Artificial Intelligence Ai Binary Code
A2z raises $4.5M in seed round for CT triage system
By AuntMinnie.com staff writers
A2z Radiology has raised $4.5 million in a seed round for R&D and the commercial deployment of its abdominal/pelvic CT triage algorithm.
December 9, 2025
Computer Brain Money 400
Virtual Phantoms launches radiation dose estimation software
By AuntMinnie.com staff writers
VirtualDoseDX allows users to adjust x-ray output and orientation to match site-specific techniques or patient protocols.
December 8, 2025
X Ray Chest Lungs
Lunit submits 510(k) to U.S. FDA for breast cancer risk prediction model
By AuntMinnie.com staff writers
The model estimates a woman's breast cancer risk from screening mammograms.
December 8, 2025
Lunit
ACR highlights 2026 HOPPS imaging-specific changes
By AuntMinnie.com staff writers
The American College of Radiology (ACR) has created a summary of imaging-specific changes included in the 2026 HOPPS final rule.
December 5, 2025
Acr Logo 2023
Siemens emphasizes AI, interventional technology at RSNA 2025
By Erik L. Ridley
Siemens expanded its AI and interventional imaging technology portfolio at RSNA 2025 in Chicago.
December 5, 2025
Syngo.CT Coronary Cockpit provides AI-powered cardiac plaque analysis.
PiB-PET/CT detects subtypes in cardiac amyloidosis
By Will Morton
PiB-PET/CT shows strong promise as a next-generation diagnostic tool for cardiac amyloidosis.
December 5, 2025
Heart
mlHealth 360 secures FDA 510(k) for ICH triage tool
By AuntMinnie.com staff writers
mlHealth 360 has received U.S. Food and Drug Administration (FDA) clearance for its Scaida BrainCT-ICH AI-powered triage software.
December 5, 2025
Am 2022 07 21 18 24 3896 Computer Brain Hemisphere 400
Lumexa Imaging launches IPO seeking up to $500M
By AuntMinnie.com staff writers
Lumexa Imaging Holdings has set the price for its initial public offering (IPO) between $17 and $20 per share.
December 5, 2025
Dollars Pile
GE HealthCare inks RT, AI partnerships
By AuntMinnie.com staff writers
GE HealthCare announced two key collaborations for its existing and new imaging technology at RSNA 2025.
December 5, 2025
Ge Hc Logo 400